Trials / Completed
CompletedNCT04335084
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 254 (actual)
- Sponsor
- ProgenaBiome · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent symptoms of COVID-19
Detailed description
In this study, subjects will take a regimen of hydroxychloroquine, vitamin C, vitamin D, and Zinc to test if this combination can prevent COVID-19. Treatment with hydroxychlorquine will last 1 day. Treatment with vitamin C, vitamin D, and and zinc will last 12 weeks. The study will last 12 weeks.
Conditions
- COVID-19
- Coronavirus Infection
- Sars-CoV2
- Corona Virus Infection
- COVID
- Coronavirus
- Coronavirus-19
- Coronavirus 19
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydroxychloroquine | Prophylaxis treatment for COVID-19 |
| DIETARY_SUPPLEMENT | Vitamin C | Prophylaxis treatment for COVID-19 |
| DIETARY_SUPPLEMENT | Vitamin D | Prophylaxis treatment for COVID-19 |
| DIETARY_SUPPLEMENT | Zinc | Prophylaxis treatment for COVID-19 |
Timeline
- Start date
- 2020-06-22
- Primary completion
- 2022-05-31
- Completion
- 2024-04-11
- First posted
- 2020-04-06
- Last updated
- 2025-06-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04335084. Inclusion in this directory is not an endorsement.